Skip to main content

Articles

3909 result(s) for 'lung cancer prognosis stage 4' within BMC Cancer

Page 42 of 79

  1. Nerve growth factor (NGF) is a neurotrophin and has been suggested to induce heme oxygenase-1 (HO1) expression. Although the role of HO1 in tumorigenesis remains controversial, recent evidence suggests NGF and...

    Authors: Sang Jae Noh, Jun Sang Bae, Urangoo Jamiyandorj, Ho Sung Park, Keun Sang Kwon, Sung Hoo Jung, Hyun Jo Youn, Ho Lee, Byung-Hyun Park, Myoung Ja Chung, Woo Sung Moon, Myoung Jae Kang and Kyu Yun Jang
    Citation: BMC Cancer 2013 13:516
  2. Progression of breast cancer involves both genetic and epigenetic factors. Parkin gene has been identified as a tumor suppressor gene in the pathogenesis of various cancers. Nevertheless, the putative role of Par...

    Authors: Khushnuma Wahabi, Ahmad Perwez, Shabeena Kamarudheen, Zafar Iqbal Bhat, Anurag Mehta and M. Moshahid A. Rizvi
    Citation: BMC Cancer 2019 19:820
  3. B-cell lymphoma 6 (BCL6) protein, an evolutionarily conserved zinc finger transcription factor, showed to be highly expressed in various human cancers in addition to malignancies in the lymphoid system. This s...

    Authors: Qiang Wu, Xue Liu, Hong Yan, Yin-huan He, Shan Ye, Xing-wang Cheng, Gui-lu Zhu, Wen-yong Wu, Xiao-nan Wang, Xiang-jun Kong, Xiao-chun Xu, Peter E Lobie, Tao Zhu and Zheng-sheng Wu
    Citation: BMC Cancer 2014 14:418
  4. We have previously reported that a new intronless gene for casein kinase 2α (CK2α), CSNK2A3, is expressed in human cells. The promoter of the well-known CK2α, CSNK2A1, displays characteristics of a housekeepin...

    Authors: Adhikarimayum Lakhikumar Sharma, Puyam Milan Meitei, Takhellambam Chanu Machathoibi, Naorem Tarundas Singh, Thiyam Ramsing Singh and Lisam Shanjukumar Singh
    Citation: BMC Cancer 2022 22:143
  5. The genetic control of prostate cancer development is poorly understood. Large numbers of gene-expression datasets on different aspects of prostate tumorigenesis are available. We used these data to identify a...

    Authors: Ivan P Gorlov, Kanishka Sircar, Hongya Zhao, Sankar N Maity, Nora M Navone, Olga Y Gorlova, Patricia Troncoso, Curtis A Pettaway, Jin Young Byun and Christopher J Logothetis
    Citation: BMC Cancer 2010 10:599
  6. Ovarian epithelial cancer (OEC) usually presents in the later stages of the disease. Factors, especially those associated with cell-cycle genes, affecting the genesis and tumour progression for ovarian cancer ...

    Authors: Narasimhan Kothandaraman, Vladimir B Bajic, Pang NK Brendan, Chan Y Huak, Peh B Keow, Khalil Razvi, Manuel Salto-Tellez and Mahesh Choolani
    Citation: BMC Cancer 2010 10:64
  7. Esophageal squamous cell carcinoma (ESCC) is one of the most common cancers worldwide. Inhibitor of kappa B kinase interacting protein (IKBIP) has been reported to promote glioma progression, but its role in o...

    Authors: Jiannan Hu, Chuanjing Dai, Zhaoji Ding, Yixiao Pan, Lingxiao Lu, Jiaqian Bao and Jingmin Zheng
    Citation: BMC Cancer 2024 24:759
  8. A plethora of prognostic biomarkers for esophageal squamous cell carcinoma (ESCC) that have hitherto been reported are challenged with low reproducibility due to high molecular heterogeneity of ESCC. The purpo...

    Authors: Meng-Xiang Li, Xiao-Meng Sun, Wei-Gang Cheng, Hao-Jie Ruan, Ke Liu, Pan Chen, Hai-Jun Xu, She-Gan Gao, Xiao-Shan Feng and Yi-Jun Qi
    Citation: BMC Cancer 2021 21:906
  9. Local recurrence after surgery and radiochemotherapy seriously affects the prognosis of locally advanced rectal cancer (LARC) patients. Studies on molecular markers related to the radiochemotherapy sensitivity...

    Authors: Heng Zhang, Xiaofan Li, Wanjun Sun, Haoren Qin, Haipeng Li, Hao Yan, Huaqing Wang, Xipeng Zhang, Shiwu Zhang and Hui Wang
    Citation: BMC Cancer 2024 24:582
  10. Novel therapeutic approaches are required to treat ovarian cancer and dependency on glycolysis may provide new targets for treatment. This study sought to investigate the variation of expression of molecular c...

    Authors: Chrysi Xintaropoulou, Carol Ward, Alan Wise, Suzanna Queckborner, Arran Turnbull, Caroline O. Michie, Alistair R. W. Williams, Tzyvia Rye, Charlie Gourley and Simon P. Langdon
    Citation: BMC Cancer 2018 18:636
  11. To demonstrate how assessment of life expectancy and loss in expectation of life can be used to address a wide range of research questions of public health interest pertaining to the prognosis of cancer patients.

    Authors: Therese M-L Andersson, Paul W. Dickman, Sandra Eloranta, Annika Sjövall, Mats Lambe and Paul C. Lambert
    Citation: BMC Cancer 2015 15:412
  12. Breast cancer is a complex and heterogeneous disease at the molecular level. Evolution is difficult to predict according to classical histoclinical prognostic factors. Different studies highlight the importanc...

    Authors: Stéphanie Fabre-Lafay, Florence Monville, Sarah Garrido-Urbani, Carole Berruyer-Pouyet, Christophe Ginestier, Nicolas Reymond, Pascal Finetti, Richard Sauvan, José Adélaïde, Jeannine Geneix, Eric Lecocq, Cornel Popovici, Patrice Dubreuil, Patrice Viens, Anthony Gonçalves, Emmanuelle Charafe-Jauffret…
    Citation: BMC Cancer 2007 7:73
  13. Correct detection of bone metastases in patients with esophageal squamous cell carcinoma is pivotal for prognosis and selection of an appropriate treatment regimen. Whole-body bone scan for staging is not rout...

    Authors: Shau-Hsuan Li, Yung-Cheng Huang, Wan-Ting Huang, Wei-Che Lin, Chien-Ting Liu, Wan-Yu Tien and Hung-I Lu
    Citation: BMC Cancer 2012 12:328
  14. BAFF and APRIL share two receptors – TACI and BCMA – and BAFF binds to a third receptor, BAFF-R. Increased expression of BAFF and APRIL is noted in hematological malignancies. BAFF and APRIL are essential for ...

    Authors: Jérôme Moreaux, Jean-Luc Veyrune, John De Vos and Bernard Klein
    Citation: BMC Cancer 2009 9:83
  15. As one of the most common cancers with high mortality in the world, we are still facing a huge challenge in the prevention and treatment of colon cancer. With the rapid development of high throughput technolog...

    Authors: Fuyan Hu, Qing Wang, Zhiyuan Yang, Zeng Zhang and Xiaoping Liu
    Citation: BMC Cancer 2020 20:668
  16. We evaluate the long-term survival of patients with peritoneal carcinomatosis (PC) treated with systemic chemotherapy regimens, and the impact of the of the retrospective peritoneal disease severity score (PSD...

    Authors: Joerg OW Pelz, Terence C Chua, Jesus Esquivel, Alexander Stojadinovic, Joerg Doerfer, David L Morris, Uwe Maeder, Christoph-Thomas Germer and Alexander G Kerscher
    Citation: BMC Cancer 2010 10:689
  17. Currently the majority of cancer patients are considered ineligible for intensive care treatment and oncologists are struggling to get their patients admitted to intensive care units. Critical care and oncolog...

    Authors: Michael von Bergwelt-Baildon, Michael J Hallek, Alexander A Shimabukuro-Vornhagen and Matthias Kochanek
    Citation: BMC Cancer 2010 10:612
  18. Previously some groups demonstrated that CD44 variant 6 (CD44v6) is correlated with progression and metastasis of ovarian cancer. However, a number of other groups failed to find such an association. Moreover,...

    Authors: Jun Shi, Zhou Zhou, Wen Di and Ningli Li
    Citation: BMC Cancer 2013 13:182

    The Retraction Note to this article has been published in BMC Cancer 2020 20:236

  19. Less than 20 % of patients with resectable oesophageal adenocarcinoma obtain a pathological response following neoadjuvant chemotherapy. Studies using oesophageal cancer cell lines have shown that drug sensiti...

    Authors: Shereen El Mashed, Tracey R. O’Donovan, Elaine Kay, Anthony O’Grady, Damian McManus, Richard C. Turkington and Sharon L. McKenna
    Citation: BMC Cancer 2022 22:908
  20. Fatty acid metabolism is reportedly associated with various cancers. However, the role of pretreatment serum free fatty acid (FFA) levels in diffuse large B-cell lymphoma (DLBCL) prognosis is still unclear, an...

    Authors: Liping Fan, Qiuyan Lin, Xiaoling Huang, Danhui Fu and Haobo Huang
    Citation: BMC Cancer 2021 21:1255
  21. Cachexia is a multi-factorial, systemic syndrome that especially affects patients with cancer of the gastrointestinal tract, and leads to reduced treatment response, survival and quality of life. The most impo...

    Authors: Tara C. Mueller, Jeannine Bachmann, Olga Prokopchuk, Helmut Friess and Marc E. Martignoni
    Citation: BMC Cancer 2016 16:75
  22. Investigating dynamic changes in blood-parameters and weight in patients with locally advanced non-small cell lung cancer (NSCLC) receiving durvalumab maintenance therapy after chemoradiotherapy (cCRT). Labora...

    Authors: J. Guggenberger, S. Kenndoff, J. Taugner, L. Käsmann, B. Flörsch, C. Belka, C. Eze and F. Manapov
    Citation: BMC Cancer 2022 22:317
  23. There is currently no standard adjuvant therapy for patients with curatively resected extrahepatic biliary tract cancer (EHBTC). The aim of this study was to analyze the clinical features and outcomes between ...

    Authors: Kyu-Hyoung Lim, Do-Youn Oh, Eui Kyu Chie, Jin-Young Jang, Seock-Ah Im, Tae-You Kim, Sun-Whe Kim, Sung Whan Ha and Yung-Jue Bang
    Citation: BMC Cancer 2009 9:345
  24. Forkhead Box P3 (Foxp3) is a regulatory T cells marker, and its expression correlates with prognosis in a number of malignancies. The aim of this study is to determine the relationship of Foxp3 expression with...

    Authors: Jing-Jing Song, Si-Jia Zhao, Juan Fang, Da Ma, Xiang-Qi Liu, Xiao-Bing Chen, Yun Wang, Bin Cheng and Zhi Wang
    Citation: BMC Cancer 2016 16:530
  25. Pancreatic neuroendocrine tumors (PNETs) are one of the most common endocrine tumors, and liver metastasis (LMs) are the most common location of metastasis from PNETS; However, there is no valid nomogram to pr...

    Authors: Jianbo Li, Long Huang, Chengyu Liao, Guozhong Liu, Yifeng Tian and Shi Chen
    Citation: BMC Cancer 2023 23:529
  26. CD147, a transmembrane glycoprotein, has been implicated in various cancer-related processes but its role in breast cancer remains poorly understood. Herein, we investigated the expression of CD147 in differen...

    Authors: Fang Li, Jing Wang, Yu-qiong Yan, Chong-zhi Bai and Ji-qiang Guo
    Citation: BMC Cancer 2023 23:1214
  27. Brain metastasis (BM) is a rare event in ovarian cancer patients. The current prognostic scores that have been used for other tumors do not account for specific characteristics of ovarian cancer, such as plati...

    Authors: Alexandre André Balieiro Anastácio da Costa, Elizabeth Santana dos Santos, Deborah Porto Cotrim, Natasha Carvalho Pandolfi, Marcelle Goldner Cesca, Henrique Mantoan, Solange Moraes Sanches, Adriana Regina Gonçalves Ribeiro, Louise de Brot, Graziele Bonvolim, Paulo Issamu Sanematsu, Ronaldo Pereira de Souza, Joyce Maria Lisboa Maya, Fabrício de Souza Castro, João Paulo da Nogueira Silveira Lima, Michael Jenwel Chen…
    Citation: BMC Cancer 2019 19:1194
  28. The rs2057482 polymorphism in the hypoxia inducible factor 1 subunit alpha (HIF1A) gene has been reported to be associated with a risk of several types of cancer, but this association has not yet been definitivel...

    Authors: Li-Fang Wu, Gui-Ping Xu, Qing Zhao, Li-Jing Zhou, Ding Wang and Wei-Xian Chen
    Citation: BMC Cancer 2019 19:1123
  29. The breast cancer microenvironment contributes to tumor progression and response to chemotherapy. Previously, we reported that increased stromal Type X collagen α1 (ColXα1) and low TILs correlated with poor pa...

    Authors: Chaohui Lisa Zhao, Kamaljeet Singh, Alexander S. Brodsky, Shaolei Lu, Theresa A. Graves, Mary Anne Fenton, Dongfang Yang, Ashlee Sturtevant, Murray B. Resnick and Yihong Wang
    Citation: BMC Cancer 2019 19:1036
  30. Anaplastic thyroid carcinoma (ATC) is among the most aggressive human malignancies. It is associated with a high rate of local recurrence and with poor prognosis.

    Authors: Olfa Derbel, Sami Limem, Céline Ségura-Ferlay, Jean-Christophe Lifante, Christian Carrie, Jean-Louis Peix, Françoise Borson-Chazot, Claire Bournaud, Jean-Pierre Droz and Christelle de la Fouchardière
    Citation: BMC Cancer 2011 11:469
  31. Bevacizumab improves progression free survival (PFS) and overall survival (OS) in metastatic colorectal cancer patients however currently there are no biomarkers that predict response to this treatment. The ai...

    Authors: Petra Martin, Sinead Noonan, Michael P Mullen, Caitriona Scaife, Miriam Tosetto, Blathnaid Nolan, Kieran Wynne, John Hyland, Kieran Sheahan, Giuliano Elia, Diarmuid O’Donoghue, David Fennelly and Jacintha O’Sullivan
    Citation: BMC Cancer 2014 14:887
  32. Often curative treatment for locally advanced resectable esophageal or gastro-esophageal junctional cancer consists of concurrent neoadjuvant radiotherapy and chemotherapy followed by surgery. Currently, one o...

    Authors: Mathieu Messager, Xavier Mirabel, Emmanuelle Tresch, Amaury Paumier, Véronique Vendrely, Laetitia Dahan, Olivier Glehen, Frederique Vasseur, Thomas Lacornerie, Guillaume Piessen, Farid El Hajbi, William B. Robb, Stéphanie Clisant, Andrew Kramar, Christophe Mariette and Antoine Adenis
    Citation: BMC Cancer 2016 16:318
  33. Gastric neoplasms containing neuroendocrine carcinoma (NEC) components are rare malignancies with highly aggressive behavior and a poor prognosis and include pure NEC and mixed tumors containing NEC components...

    Authors: Jiahui Chen, Anqiang Wang, Ke Ji, Zhaode Bu and Jiafu Ji
    Citation: BMC Cancer 2020 20:777
  34. Aldehyde dehydrogenase 2 (ALDH2) plays an important role in the endogenous aldehyde detoxification of various types of cells. ALDH2*2, a variant allele of the ALDH2 polymorphism rs671, leads to decreased enzymati...

    Authors: Akiko Matsumoto, Chiho Nakashima, Shinya Kimura, Eizaburo Sueoka and Naoko Aragane
    Citation: BMC Cancer 2021 21:584
  35. The HECT family ubiquitin ligase Smurf2 regulates cell polarity, migration, division, differentiation and death, by targeting diverse substrates that are critical for receptor signaling, cytoskeleton, chromati...

    Authors: Xianpeng Liu, Xin Gu, Limin Sun, Ashley B Flowers, Alfred W Rademaker, Yiran Zhou and Hiroaki Kiyokawa
    Citation: BMC Cancer 2014 14:57
  36. Toll-like receptor 3 (TLR3) plays a key role in innate immunity. In the present study, we analyzed tissues of patients with human hepatocellular carcinoma (HCC) to determine the significance of the relationshi...

    Authors: Ming-Ming Yuan, Yu-Yin Xu, Li Chen, Xing-Yu Li, Jing Qin and Ying Shen
    Citation: BMC Cancer 2015 15:245
  37. Novel antibody‒drug conjugates (ADC) have shown great efficacy in HER2-low advanced breast cancer. However, the clinical features of HER2-low disease still need to be clarified. The current study aims to evalu...

    Authors: Qin Shi, Jing Yu, Deyue Liu, Fang Ren, Jiayi Wu and Kunwei Shen
    Citation: BMC Cancer 2023 23:173
  38. Pan-immune-inflammation value (PIV) is defined by the neutrophil, platelet, monocyte, and lymphocyte counts and is associated with immune-checkpoint inhibitor (ICI) therapy outcomes in advanced non-small cell ...

    Authors: Yiqun Chen, Lingyan Gong, Pengyang Gu, Yiwen Hua, Yingfang Sun, Songshi Ni, Xiaoyu Zhou and Zhiyuan Tang
    Citation: BMC Cancer 2023 23:944
  39. We used pyroptosis-related genes to establish a risk–score model for prognostic prediction of liver hepatocellular carcinoma (LIHC) patients. A total of 52 pyroptosis-associated genes were identified. Then, da...

    Authors: Xinyi Chen, Mu Yang, Lu Wang, Yuan Wang, Jingyao Tu, Xiao Zhou and Xianglin Yuan
    Citation: BMC Cancer 2023 23:411
  40. The main treatment methods for early gastric cancer (EGC) include endoscopic submucosal dissection (ESD) and radical gastrectomy. However, appropriate treatment for patients who exceed the absolute indications...

    Authors: Zhi Zheng, Jie Yin, Ziyu Li, Yingjiang Ye, Bo Wei, Xin Wang, Yantao Tian, Mengyi Li, Qian Zhang, Na Zeng, Rui Xu, Guangyong Chen, Jie Zhang, Peng Li, Jun Cai, Hongwei Yao…
    Citation: BMC Cancer 2020 20:801
  41. Distal esophageal adenocarcinoma is a highly aggressive neoplasm. Despite advances in diagnosis and therapy, the prognosis is still poor. Stathmin (STMN-1) is a ubiquitously expressed microtubule destabilizing...

    Authors: Javed Akhtar, Zhou Wang, Che Yu, Chen-Sheng Li, Yu-Long Shi and Hong-Jun Liu
    Citation: BMC Cancer 2014 14:28

    The Retraction Note to this article has been published in BMC Cancer 2015 15:187

  42. We previously reported that polyploid giant cancer cells (PGCCs) exhibit cancer stem cell properties and express cell cycle-related proteins. HEY PGCCs induced by cobalt chloride generated daughter cells and t...

    Authors: Hongcheng Lv, Yang Shi, Li Zhang, Dan Zhang, Guang Liu, Zhengduo Yang, Yan Li, Fei Fei and Shiwu Zhang
    Citation: BMC Cancer 2014 14:576
  43. Immune checkpoint inhibitors (ICI) have become standard treatment in different tumor entities. However, safe treatment with ICI targeting the PD-1/PD-L1 axis requires early detection of immune-related adverse ...

    Authors: Luisa Maria Griewing, Claudia Schweizer, Philipp Schubert, Sandra Rutzner, Markus Eckstein, Benjamin Frey, Marlen Haderlein, Thomas Weissmann, Sabine Semrau, Antoniu-Oreste Gostian, Sarina K. Müller, Maximilian Traxdorf, Heinrich Iro, Jian-Guo Zhou, Udo S. Gaipl, Rainer Fietkau…
    Citation: BMC Cancer 2021 21:314
  44. To determine whether magnetic resonance imaging (MRI)-detected extramural vascular invasion (mrEMVI) status is associated with quantitative perfusion parameters derived from dynamic contrast-enhanced MRI (DCE-...

    Authors: Yan Chen, Xinyue Yang, Ziqiang Wen, Yiyan Liu, Baolan Lu, Shenping Yu and Xiaojuan Xiao
    Citation: BMC Cancer 2019 19:498
  45. Thymidine kinase 1 (TK1) is a cellular enzyme involved in DNA precursor synthesis, and its activity has been used as a proliferation marker for monitoring malignant diseases. Here, for the first time, we evalu...

    Authors: Kiran Kumar Jagarlamudi, Lars Olof Hansson and Staffan Eriksson
    Citation: BMC Cancer 2015 15:66
  46. Breast carcinoma (BC) ranks as a predominant malignancy and constitutes the second principal cause of mortality among women globally. Epirubicin stands as the drug of choice for BC therapeutics. Nevertheless, ...

    Authors: Yunwei Zhang, Yunping Guan, Xinyu Zheng and Chenyang Li
    Citation: BMC Cancer 2024 24:167
  47. Our aim was to develop a validated Patient Reported Experience Measure (PREM) to capture patient and carer experience during participation in experimental cancer medicine trials (ECM): called PREM-ECM.

    Authors: Chelsea S. Sawyer, Sally Taylor, Louise Carter, Melissa Stanworth, Michelle Davies, Fiona Thistlethwaite, Jo Taylor, Charlotte Eastwood and Janelle Yorke
    Citation: BMC Cancer 2024 24:500

Featured videos

View featured videos from across the BMC-series journals